कृपया अन्य खोज का प्रयास करें
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Michael D. Webb | - | 2022 | Director |
Frank Pasqualone | - | 2022 | Director |
Bevin O'Neil | - | 2022 | Director |
Michael D. Webb | 65 | 2022 | Independent Chairman of the Board |
Stephen M. Stahl | - | 2022 | Member of Scientific Advisory Board |
Frank Pasqualone | 68 | 2022 | Independent Director |
Maurizio Fava | - | 2022 | Chairman of Scientific Advisory Board |
Michael B. Liebowitz | - | 2022 | Member of Scientific Advisory Board |
George A. Kegler | 68 | 2020 | Independent Non-Employee Director |
Joseph Edward Tucker | 55 | 2021 | CEO & Director |
Marcus Schabacker | 60 | 2020 | Independent Non-Employee Director |
John H. Krystal | - | 2022 | Member of Scientific Advisory Board |
Sheila DeWitt | 63 | 2022 | Independent Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है